Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

https://soho2018.org/

 

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
A

Oral Abstract ALL 131: Safety and Efficacy of the BCL Inhibitors Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

By Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018) FEATURING Andrew Hantel
By Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018) FEATURING Andrew Hantel
19 views
November 5, 2018
0 Comments
Login to view comments. Click here to Login

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay
Session IV: Acute Lymphoblastic Leukemia
18:57
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

MLL Leukemias: A Remaining Hurdle

Feat. R. Pieters
21:00
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

CART T Cells in ALL - CD19, CD22 and Development of Bivalent CAR, Di…

Feat. T. Fry
17:59
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

Combining Molecular Genetics and Cytogenetics for Prognostication

Feat. H. Dombret
21:19
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

Can MRD Monitoring Be Done Using Peripheral Blood?

Feat. L. Muffly
17:42
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

T-ALL: Nelarabine In The Frontline; And What To Do About Relapse?

Feat. D. DeAngelo
12:25
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

Oral Abstract ALL 131: Safety and Efficacy of the BCL Inhibitors Ven…

Feat. A. Hantel